Wilson J R, Limaye A P
Departments of Laboratory Medicine and Medicine, University of Washington Medical Center, 1959 Northeast Pacific Street, Box 357110, Seattle, WA 98195-7110, USA.
Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):310-6. doi: 10.1007/s10096-004-1111-y. Epub 2004 Mar 13.
Risk factors for mortality in anaerobic bacteremia have been incompletely defined. The aims of the present study were to determine clinical significance by pathogen for a broad range of obligate anaerobic organisms isolated from blood, and to define the factors independently associated with mortality among those with clinically significant bacteremia. All patients who had anaerobic bacteria isolated from blood over a 19-month period (from 1 September 1998 to 1 April 2000) at two urban teaching hospitals were included in this study. Each case was analyzed for clinical significance by means of a retrospective medical record review using predetermined definitions. Information was collected on a broad range of clinical and microbiological factors, which were evaluated for their association with mortality using a Cox proportional hazards model. Among 166 patients with obligate anaerobic bacteria isolated from blood, 73 (44%) were deemed to have clinically significant bacteremia. Clinical significance ranged from 0% (0/53) for Propionibacterium spp. to 96% (43/45) for Bacteroides spp. The crude mortality rate in patients with clinically significant anaerobic bacteremia was 25% (18/73). Mortality was significantly associated with age, polymicrobial infection, and underlying heart, kidney or liver disease in univariate analysis. Only the presence of liver disease (relative risk, 5.3; 95% confidence interval, 1.7-16.0; P=0.003) and patient age (relative risk, 1.06/y; 95% confidence interval, 1.0-1.1; P=0.005) remained significant in multivariate analysis. Among patients with anaerobic bacteremia, clinical significance varies markedly by pathogen and mortality is independently associated with age and underlying liver disease.
厌氧菌血症患者的死亡风险因素尚未完全明确。本研究的目的是确定从血液中分离出的多种专性厌氧生物的病原体的临床意义,并确定在具有临床意义的菌血症患者中与死亡率独立相关的因素。本研究纳入了在两家城市教学医院19个月期间(从1998年9月1日至2000年4月1日)从血液中分离出厌氧细菌的所有患者。通过使用预先确定的定义进行回顾性病历审查,对每个病例的临床意义进行分析。收集了广泛的临床和微生物学因素信息,并使用Cox比例风险模型评估它们与死亡率的关联。在166例从血液中分离出专性厌氧细菌的患者中,73例(44%)被认为患有具有临床意义的菌血症。临床意义范围从丙酸杆菌属的0%(0/53)到拟杆菌属的96%(43/45)。具有临床意义的厌氧菌血症患者的粗死亡率为25%(18/73)。在单因素分析中,死亡率与年龄多微生物感染以及潜在的心脏、肾脏或肝脏疾病显著相关。在多因素分析中,只有肝病的存在(相对风险,5.3;95%置信区间,1.7 - 16.0;P = 0.003)和患者年龄(相对风险,1.06/岁;95%置信区间,1.0 - 1.1;P = 0.005)仍然具有显著性。在厌氧菌血症患者中,临床意义因病原体而异,死亡率与年龄和潜在肝病独立相关。